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Abstract
Background: Pregnant women are a major risk group for malaria in endemic areas. Only little
information exists on the compliance of pregnant women with malaria and anaemia preventive drug
regimens in the rural areas of sub-Saharan Africa (SSA). In this study, we collected information on
malaria and anaemia prevention behaviour in pregnant women of rural Burkina Faso.
Methods: Cross-sectional qualitative and quantitative survey among 225 women of eight villages
in rural northwestern Burkina Faso. Four of the villages had a health centre offering antenatal care
(ANC) services while the other four were more than five kilometers away from a health centre.
Results: Overall ANC coverage (at least one visit) was 71% (95% in health centre villages vs 50%
in remote villages). Malaria and anaemia were considered as the biggest problems during pregnancy
in this community. ANC using women were quite satisfied with the quality of services, and
compliance with malaria and anaemia prevention regimens (chloroquine and iron/folic acid) was
high in this population. Knowledge on the benefit of bed nets and good nutrition was less
prominent. Distance, lack of money and ignorance were the main reasons for women to not attend
ANC services.
Conclusions: There is an urgent need to improve access of rural SSA women to ANC services,
either through increasing the number of rural health centres or establishing functioning outreach
services. Moreover, alternative malaria and anaemia prevention programmes such as intermittent
preventive treatment with effective antimalarials and the distribution of insecticide-treated bed
nets need to become implemented on a large scale.
Background
Each year between 75.000 and 200.000 infant deaths are
attributed to malaria infection in pregnancy globally, and
between 200.000 and 500.000 pregnant women develop
severe anaemia as a result of malaria in Sub-Saharan
Africa (SSA) [1]. Pregnant compared to non-pregnant
women are at an increased risk for malaria, and the sever-
ity of the clinical manifestations in the women and her
foetus depends on the level of pre-pregnancy immunity
[2]. While in areas of low malaria endemicity all pregnant
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malaria infection, in areas of high endemicity women
appear to be most susceptible during their first pregnancy
[3]. However, more recent publications point to signifi-
cant susceptibility in primigravidae as well as in multi-
gravidae [4].
Pregnancies in women living in malaria endemic regions
are associated with a high frequency and density of P. fal-
ciparum parasitaemia, with high rates of maternal morbid-
ity including fever and severe anaemia, with abortion and
stillbirth, and with high rates of placental malaria and
consequently low birth weight in newborns caused by
both prematurity and intrauterine growth retardation
[1,3,5].
In order to reduce malaria-related ill health, regular chem-
oprophylaxis has been recommended to all pregnant
women living in malaria-endemic areas [6]. Most African
countries, including Burkina Faso, include routine chem-
oprophylaxis in their official antenatal care programmes.
However, in practice, coverage of chemoprophylaxis is
limited due to low accessibility and quality of antenatal
care (ANC) services as well as problems with compliance
[7]. It has been estimated from a survey in four African
countries that less than 20% of women use a prophylactic
regimen close to the WHO recommendations [8].
While insecticide-treated bed nets and curtains (ITN) have
been shown to substantially reduce malaria morbidity
and mortality in children, results from initial trials on the
efficacy of ITNs for malaria prevention in pregnancy pro-
duced conflicting evidence and were classified as incon-
clusive by the Cochrane Collaboration [3,9]. However,
with the publication of the findings from a major ITN trial
in a holoendemic area of western Kenya, the use of ITN
during pregnancy is getting more credibility [10].
In Burkina Faso, the official policy for malaria and anae-
mia prevention in pregnant women comprises of chloro-
quine and iron/folic acid supplementation respectively.
However, in the rural areas of Burkina Faso little informa-
tion exists on coverage with ANC and on compliance with
preventive regimens. We assessed the coverage of antena-
tal care and investigated the knowledge and adoption of
preventive practices with respect to malaria and anaemia
in users and non-users of antenatal care.
Methods
Study area
The study took place in the rural part of the research zone
of the Centre de Recherche en Santé de Nouna (CRSN) in
Nouna Health District, northwestern Burkina Faso. The
CRSN research zone consists of Nouna town and 41 of the
surrounding villages with a total population of around
60.000 inhabitants. The Nouna area is a dry orchard
savanna, populated mainly by subsistance farmers of dif-
ferent ethnic groups.
Malaria is holoendemic but highly seasonal in this part of
Westafrica [11]. Most malaria transmission takes place
during or shortly after the rainy season which usually lasts
from June until October [11]. Modern health services in
the CRSN research zone are limited to four village-based
health centres and the district hospital in Nouna town. As
a consequence, malaria control is mainly based on home
treatment with chloroquine, the official first-line treat-
ment drug in Burkina Faso. Roughly half of all house-
holds in the area possess at least one untreated bed net
and since 2000, ITN are distributed as part of an ongoing
trial in young children [12,13].
The official policy for malaria and anaemia prevention
during pregnancy in Burkina Faso consists of a curative
dose of 1 500 mg chloroquine during three days followed
by a weekly dose of 300 mg chloroquine and a combined
dose of daily 200 mg iron and 0.25 mg folic acid. This reg-
imen should be followed from the first ANC visit until six
weeks after delivery. Since the year 2002 it is the official
policy in Burkina Faso to offer ANC services free of charge.
This includes ANC card, physical examination and coun-
selling, and malaria/anaemia prevention drugs. However,
urine examination, gloves, and drugs for other concomi-
tant diseases still have to be paid for. Urine examination
and gloves usually cost 150–200 F CFA (1 Euro = 650 F
CFA).
Study design
The study was cross-sectional and descriptive in nature,
using both qualitative and quantitative methods for data
collection. The study was implemented in May and June
2003. The research team comprised of the investigators
and six trained local interviewers familiar with the com-
mon spoken local languages and French. The question-
naires were pre-tested before administration.
The study took place in eight of the 41 villages of the
CRSN study area. Villages were selected as follows: At a
first stage, the four villages of the CRSN study area where
a health centre exists were purposely selected. To account
for the socio-demographic variability and geographical
accessibility, in each of these health centre defined sub-
areas, another village distant of at least 5 kilometres to the
health centre was randomly selected.
Qualitative research
We conducted six Focus Group Discussions (FGD). Two
with pregnant women users of ANC, two with husbands
of pregnant women users of ANC, and two with pregnant
women non-users of ANC. Respective FGDs were heldPage 2 of 7
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with and without a health centre.
Key informant interviews were conducted with four
maternity health workers, seven traditional birth attend-
ants and 29 women group leaders. The interviews assessed
their knowledge, attitudes and practices about malaria
and anaemia prevention in pregnancy.
Quantitative research
The design of the quantitative survey instrument was
informed by the results of the qualitative interviews. A
structured questionnaire was administered to all women
from the eight study villages who had delivered a life child
during the last six months (n = 225). Information on
births was available through the existing Demographic
Surveillance System (DSS) in the study area [14]. The
questions focussed on socio-demographic characteristics,
obstetrical history, knowledge and practice of preventive
measures against malaria and anaemia during pregnancy,
factors influencing the utilisation of ANC services and on
the compliance with chloroquine and iron/folic acid sup-
plementation during pregnancy. The questionnaires were
filled in by the interviewers who also cross-checked given
answers with all available ANC cards (n = 156/225).
On the ANC cards, the estimated age of pregnancy at first
visit was reported through the fundal height in centime-
tres, as women were not able to recall their last menstrua-
tion period during ANC visits. These data were afterwards
transformed into a specific scoring system.
We used two definitions for malaria prophylaxis. A com-
plete curative dose of 1 500 mg chloroquine followed by
regularly weekly 300 mg doses afterwards (complete
prophylaxis), and an incomplete regimen consisting of
only 300 mg weekly doses (incomplete prophylaxis). A
combined dose of daily 200 mg iron and 0.25 mg folic
acid was defined as a complete prophylaxis.
Statistical analysis
The data were entered in Microsoft Access 2000, cleaned,
and then analysed with Epi Info 2000. Univariate analysis
was done with chi-square test or Fisher's exact test to com-
pare proportions for categorical variables. Results were
considered to be significant when the 2-sided P value was
<0.05.
Ethical aspects
We received ethical approval from the institutional Ethical
Committee at the Department of Tropical Hygiene in Hei-
delberg, Germany, and the local Ethical Committee in
Nouna, Burkina Faso. Oral informed consent was
obtained from all participants.
Results
Study population
The characteristics of participants on the quantitative sur-
vey are shown in table 1. The great majority of the survey
women were married, illiterate, housewife/farmers and
their ages range between 15 and 49 years. The distribution
of ethnicity among survey women was as follows: 41%
Bwaba, 39% Marka, 15% Mossi, 3% Samo and 2% others.
The median number of pregnancies among survey women
was 6 (range 1–13). There were no differences between
the background characteristics of users compared to non-
users of ANC services, except regarding distance to the
nearest ANC services. When comparing women living at a
distance ≤ 5 km with women living >5 km, distance was
significantly associated with ANC use (p < 0.001).
ANC coverage
In this study population, the minimal ANC coverage
(defined as at least one ANC visit during pregnancy) was
159/225 (71%) and 63/225 (28%) if we consider the
optimal frequency of at least three ANC visits (national
goal). Minimal ANC coverage was 97/102 (95%) in vil-
lages with a health centre vs 62/123 (50%) in remote vil-
lages (p < 0.001), while the optimal ANC coverage was
55/102 (54%) in villages with a health centre vs 8/123
(7%) in remote villages (p < 0.001).
Among ANC users, 27%, 40% and 33% of women visited
ANC services one time, two times or more than two times
respectively during their pregnancy. The first ANC visit of
ANC users was in 14% during the first trimester, in 57%
during the second trimester, and in 27% during the third
trimester.
Malaria and anaemia prevention knowledge and 
behaviour
Malaria and anaemia were considered as the most com-
mon diseases during pregnancy by the majority of the par-
ticipants in the FGD, key informant interviews and survey
women. In the Dioula language (lingua franca in the
region) malaria is equivalent to "Soumaya", light to mod-
erate anaemia to "Djolidessé" and severe anaemia to
"Djoliban". Most women in the FGD were knowledgeable
about the malaria prevention effect of chloroquine and
the anaemia prevention effect of iron/folic acid.
The knowledge of malaria and anaemia prevention meas-
ures by ANC users is given in table 2. Regarding malaria,
the majority of survey women stated that it can be pre-
vented with chloroquine (white tablets), while only a
minority mentioned mosquito nets or others measures.
Regarding anaemia, iron/folic acid (red colour tablets or
vitamins) supplementation was stated by the majority of
survey women as being protective, while a much smaller
percentage of women mentioned nutrition as an impor-Page 3 of 7
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vention measures against malaria and iron/folic acid
against anaemia was significantly associated with ANC
use (p < 0.002; p < 0.001; p < 0.001).
Table 3 shows data on self-reported use of malaria and
anaemia prophylaxis with chloroquine and iron/folic acid
in the population of ANC users together with respective
data taken from their ANC cards. A correct prescription of
chloroquine (complete prophylaxis) on ANC cards was
seen in 60%, and a correct prescription of iron/folic acid
(complete prophylaxis) was seen in 78%. In contrast, self-
reported oral information during ANC visits on complete
and incomplete prophylaxis regimens were lower and
matched well with self-reported information on the chlo-
roquine and iron/folic acid dosages taken. Most women
reported being compliant with the oral information on
chloroquine and iron/folic acid regimens from first ANC
visit until delivery.
Factors influencing the use of ANC services
Of ANC users, the great majority reported to be satisfied
with the quality of ANC services. Only 16% of ANC users
were aware of the fact that ANC services have recently
become free of charge, and 42% reported that they still
had paid for services. Most (73%) ANC users had paid
between zero and 200 F CFA, while 12% and 6% had paid
between 200 and 1.500 and between 1.500 and 7.500 F
CFA respectively.
Apart from distance to the next health centre, lack of
resources and ignorance were the most frequent stated
Table 1: Background characteristics of women interviewed
ANC
Background Characteristics (%) Users n = 159 Non Users n = 66 All n = 225
Age Group
15–19 24 (15) 12 (18) 36 (16)
20–29 81 (51) 37 (56) 118 (52)
30–49 54 (34) 17 (26) 71 (32)
Education
No Schooling 145 (91) 62 (94) 207 (92)
Primary Education 14 (9) 4 (6) 18 (8)
Parity
1 26 (16) 8 (12) 34 (15)
2–3 46 (29) 17 (26) 63 (28)
4–13 87 (55) 41 (62) 128 (57)
Distance*(Km)
0–4 99 (62) 5 (8) 104 (46)
5–7 43 (27) 59 (89) 102 (45)
8–15 17 (11) 2 (3) 19 (8)
* Distance to the nearest health center in kilometers
Table 2: Knowledge of preventive measures against malaria and anemia
ANC All P Value
Knowledge factors (%) Users n = 159 Non Users n = 66 All n = 225 p-value
Malaria prevention
Chloroquine 128 (66) 35 (59) 163 (65) <0.001
Mosquito nets 40 (21) 2 (3) 42 (17) < 0.001
Hygiene 6 (3) 3 (5) 9 (4) n.s.
Protective clothing 12 (6) 0 (0) 12 (5) <0.05
Does not know 7 (4) 19 (32) 26 (10) <0.001
Anemia prevention
Iron/Folic acid 129 (76) 16 (25) 145 (63) <0.001
Adequate nutrition 29 (17) 8 (13) 37 (16) n.s.
Does not know 11 (7) 39 (62) 50 (22) <0.001Page 4 of 7
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why women did not attend ANC services. The majority of
ANC non-users reported no specific prophylaxis during
their pregnancy, but 6% took irregularly self medication
for malaria/anaemia prevention. Moreover, 30% of ANC
non-users had sought advice from traditional birth
attendants (TBA).
Typical statements in the FGDs with non-users of ANC
services werecollected as follow:
• "ANC is not free of charge, you must pay for ANC card and
the medicine and it could be up to 500 CFA and for me I find
it is expensive. Our husbands find it expensive too, that is why
the majority of us can not attend ANC services".
• "I don't know the advantages of ANC services, some of the
pregnant women if they don't fell sick they wouldn't accept to
attend ANC ".
• "There is lack of advices from health workers, if you go to the
ANC for the 1sttime, they give drugs, they don't tell you when
you should come back and how many visits you should attend.
That is how they do here".
• "If you are not sick, you don't pay for drugs, what you pay for
is the ANC card at 150 F CFA...."
• " But even the ANC card is free of charge, only the gloves cost
100 F CFA...."
• "I had not yet heard about the free ANC services ... Since I
know now that ANC is free of charge I will attend the services."
• "We do not have money to go to the health centre it will be
nice to have one in our village".
Itching, vomiting and fatigue were the most frequently
stated side effects of malaria/anaemia prevention drug
regimens during interviews, sometimes leading to non-
compliance. Most women also stated that bed nets are
considered too expensive for their household.
Discussion
The main findings of this study are (1) that coverage of
antenatal care is far from complete, particularly in villages
without a health centre, (2) that malaria- and anaemia-
related knowledge and compliance with preventive meas-
ures is comparatively high with a wide gap between users
and non-users of antenatal care and (3) that health serv-
ices need to improve their response to the women's need
for preventive care in pregnancy.
Use and coverage of antenatal care
In this community-based study from a rural area of
Burkina Faso, we found an overall ANC coverage of 71%,
which is however not representative given the used meth-
odology. Most women had two ANC visits during their
pregnancy, mainly during the second and third trimester.
As we found ANC coverage to be much higher in villages
with a health centre compared to villages quite distant
Table 3: Prescription in ANC card of chloroquine prophylaxis and iron/folic acid supplemen-tation, self-reported ANC instructions and 
self-reported intake among ANC users (n = 159)
Chloroquine (%) Iron/folic acid (%)
Prescription on ANC card
Complete prophylaxis 95 (60) 124 (78)
Incomplete prophylaxis 29 (18) -
Incorrect prescription 32 (20) 32 (20)
No prescription (no ANC card) 3 (2) 3 (2)
Instructions given at ANC visits (self-reported)
Complete prophylaxis explained 46 (29) 111 (70)
Incomplete prophylaxis explained 65 (41) -
Incorrect instructions given 41 (26) 41 (26)
No instructions given 7 (4) 7 (4)
Dosages taken (self-reported)
Complete prophylaxis 46 (29) 149 (94)
Incomplete prophylaxis 67 (42) -
Incorrect dose 43 (27) 8 (5)
No prophylaxis 3 (2) 2 (1)
Duration of chloroquine and iron/folic acid prophylaxis
From 1st ANC until before delivery 20 (13) 20 (13)
From 1st ANC until delivery 115 (72) 124 (78)
From 1st ANC until after delivery 21 (13) 13 (8)
No prophylaxis 3 (2) 2 (1)Page 5 of 7
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of health centre and non-health centre villages, our ANC
coverage figure is likely to be an overestimate. The
national demographic and health survey in Burkina Faso
claims an ANC attendance (at least one ANC during one
pregnancy) of 59% [15]. Although health workers from
rural health centres in Burkina Faso are advised to do reg-
ularly outreach work in the villages of their respective
catchment areas, in practice such visits are rare due to a
number of reasons such as lack of transport. Our findings
thus support the need for better access of rural SSA
women to ANC services [16].
Other reasons given for non-use of ANC services included
ignorance and lack of money. This confirms similar obser-
vations from other rural African areas [20]. Interestingly,
the Burkinabé Government had recently changed its pol-
icy towards free ANC service provision. However, our
findings show that this policy is rather confusing as some
parts of ANC procedures are not included. Consequently
it was not yet fully understood by the population. How-
ever, this change in policy was considered promising dur-
ing our interviews, and it was also reassuring that most of
the ANC users were satisfied with the quality of ANC
services.
Knowledge and compliance with preventive interventions 
related to malaria and anaemia
Malaria and anaemia were seen as important disease enti-
ties during pregnancy in our interviews. Moreover, most
women interviewed were quite knowledgeable about
effective malaria/anaemia prevention measures. However,
compared to ANC users ANC non-users were significantly
less knowledgeable about malaria/anaemia prevention
measures. The interpretation is not straight forward
because more knowledgeable women may be more likely
to attend antenatal care or increased knowledge may be
the result of health education in anatenatal care; most
likely both effects contribute to the observed gap between
ANC users and ANC non-users.
Responsiveness of health services
There is now a broad agreement on the need of new strat-
egies for community participation on the implementation
of effective malaria control activities, as well as for a better
education of service providers of both the public and the
private sector [17].
It was reassuring to find nearly all of the women with
reported ANC use to have an ANC card in their house.
Specific prescriptions were found on most cards, but in
particular malaria prophylaxis prescriptions were often
not complete. This explains why self-reported compliance
with recommended prevention regimens was sub-optimal
with regard to malaria. Such discrepancies have been
observed already in a recent study in pregnant women of
Nouna town [18]. However, self-reported compliance
matched well with the reported oral instructions given by
respective health workers. This points to the importance
of correct oral information in rural areas with high preva-
lence of illiteracy [19].
The best model for effective and cost-effective malaria pre-
vention during pregnancy in SSA still needs to be devel-
oped. Chloroquine has been the mainstay for malaria
control in sub-Saharan Africa (SSA), but the emergence of
chloroquine-resistant Plasmodium falciparum has put into
question the efficacy of this well-known drug [21]. The
first cases of in vitro and in vivo Chloroquine resistance in
Burkina Faso were seen in 1983 and 1988, respectively,
and reported clinical failure rates after use of Chloroquine
for treatment of uncomplicated malaria in children were
around 5% in the early 1990s and 10% during the most
recently performed surveys [22]. Although this is consid-
ered still below the threshold of clinical failures consid-
ered to require a change of first-line treatment, it has
recently been shown that chloroquine failed to prevent
malaria in pregnant women of Burkina Faso [23]. Current
alternatives include intermittent treatment with pyrimeth-
amine-sulfadoxine and the use of ITNs. Sulphadoxine-
pyrimethamine, given in 1–3 therapeutic dosages during
the second and third trimester of pregnancy, has recently
been demonstrated to be an effective and cost-effective
schedule for malaria prevention [24]. Compared to chlo-
roquine prophylaxis, this regimen has the advantage that
it is given to women when they attend antenatal clinics,
thus avoiding problems with compliance. ITNs are
increasingly considered as an important tool in the pre-
vention of malaria in young children and pregnant
women, and the provision of ITN through ANC services
has recently been proposed as a promising distribution
channel [13,25]. The findings of this study confirm the
cost barrier to the private purchase of bed nets and ITNs
and thus support the call for major subsidies if a high ITN
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